These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

127 related items for PubMed ID: 27516

  • 1. Metabolism of prostacyclin in blood vessels.
    Wong PY, Sun FF, McGiff JC.
    J Biol Chem; 1978 Aug 25; 253(16):5555-7. PubMed ID: 27516
    [Abstract] [Full Text] [Related]

  • 2. An NADP-linked prostacyclin dehydrogenase in rabbit kidney.
    Korff JM, Jarabak J.
    Prostaglandins; 1981 May 25; 21(5):719-25. PubMed ID: 7041194
    [Abstract] [Full Text] [Related]

  • 3. Metabolism of 6-ketoprostaglandin F1 alpha and prostacyclin to 6,15-diketo-13,14-dihydroprostaglandin F1 alpha-like material in cats and rabbits.
    Förstermann U, Neufang B, Hertting G.
    Biochim Biophys Acta; 1982 Sep 14; 712(3):684-91. PubMed ID: 6751407
    [Abstract] [Full Text] [Related]

  • 4. Metabolism of prostacyclin: formation of an active metabolite in the liver.
    Wong PY, Lee WH, Quilley CP, McGiff JC.
    Fed Proc; 1981 May 15; 40(7):2001-4. PubMed ID: 7014260
    [Abstract] [Full Text] [Related]

  • 5. Studies of the mechanisms involved in the fate of prostacyclin (PGI2) and 6-keto-PGF1alpha in the pulmonary circulation.
    Hawkings HJ, Smith JB, Nicolaou KC, Eling TE.
    Prostaglandins; 1978 Dec 15; 16(6):871-84. PubMed ID: 219443
    [Abstract] [Full Text] [Related]

  • 6. 9-Hydroxyprostaglandin dehydrogenase in rat kidney cortex converts prostaglandin I2 into 15-keto-13,14-dihydro 6-ketoprostaglandin E1.
    Pace-Asciak CR, Domazet Z.
    Biochim Biophys Acta; 1984 Nov 14; 796(2):129-35. PubMed ID: 6388642
    [Abstract] [Full Text] [Related]

  • 7. Metabolism of prostacyclin. III. Urinary metabolite profile of 6-keto PGF1 alpha in rat.
    Sun FF, Taylor BM, Sutter DM, Weeks JR.
    Prostaglandins; 1979 May 14; 17(5):753-9. PubMed ID: 386428
    [Abstract] [Full Text] [Related]

  • 8. Pulmonary metabolism of prostacyclin (PGI2) in the rabbit.
    Wong PY, McGiff JC, Sun FF, Malik KU.
    Biochem Biophys Res Commun; 1978 Jul 28; 83(2):731-8. PubMed ID: 29629
    [No Abstract] [Full Text] [Related]

  • 9. The human placental anti-aggregating factor is neither prostacyclin, nor a prostacyclin metabolite.
    Dembélé-Duchesne MJ, Thaler-Dao H, Chavis C, Crastes de Paulet A.
    Prostaglandins; 1982 Nov 28; 24(5):701-14. PubMed ID: 6298904
    [Abstract] [Full Text] [Related]

  • 10. Comparison of substrate specificities of the human placental NAD- and NADP-linked 15-hydroxyprostaglandin dehydrogenases.
    Jarabak J, Fried J.
    Prostaglandins; 1979 Aug 28; 18(2):241-6. PubMed ID: 42948
    [Abstract] [Full Text] [Related]

  • 11. Formation and elimination of prostacyclin metabolites in the cat in vivo as determined by radioimmunoassay of unextracted plasma.
    Machleidt C, Förstermann U, Anhut H, Hertting G.
    Eur J Pharmacol; 1981 Aug 27; 74(1):19-26. PubMed ID: 7032951
    [Abstract] [Full Text] [Related]

  • 12. Metabolism of (5E)-6a-carbaprostaglandin I2 by rhesus monkey lung 15-OH prostaglandin dehydrogenase.
    McGuire JC, Morton DR, Brokaw FC, Sun FF.
    Prostaglandins; 1981 Apr 27; 21(4):609-14. PubMed ID: 7019975
    [Abstract] [Full Text] [Related]

  • 13. Prostaglandin metabolism in the fetal and maternal vasculature.
    Terragno NA, Terragno A.
    Fed Proc; 1979 Jan 27; 38(1):75-7. PubMed ID: 759241
    [Abstract] [Full Text] [Related]

  • 14. PGI2 production by rat blood vessels: diminished prostacyclin formation in veins compared to arteries.
    Skidgel RA, Printz MP.
    Prostaglandins; 1978 Jul 27; 16(1):1-16. PubMed ID: 360298
    [Abstract] [Full Text] [Related]

  • 15. Metabolism of prostacyclin by 9-hydroxyprostaglandin dehydrogenase in human platelets. Formation of a potent inhibitor of platelet aggregation and enzyme purification.
    Wong PY, Lee WH, Chao PH, Reiss RF, McGiff JC.
    J Biol Chem; 1980 Oct 10; 255(19):9021-4. PubMed ID: 6997309
    [Abstract] [Full Text] [Related]

  • 16. Metabolism of prostacyclin and 6-keto-prostaglandin F1 alpha in man.
    Rosenkranz B, Fischer C, Weimer KE, Frölich JC.
    J Biol Chem; 1980 Nov 10; 255(21):10194-8. PubMed ID: 7000774
    [Abstract] [Full Text] [Related]

  • 17. Enhanced prostacyclin availability of blood vessels in uraemic humans and rats.
    Leithner C, Winter M, Silbauer K, Wagner O, Pinggera W, Sinzinger H.
    Proc Eur Dial Transplant Assoc; 1978 Nov 10; 15():418-23. PubMed ID: 368786
    [Abstract] [Full Text] [Related]

  • 18. Metabolic disposition of prostacyclin in humans.
    Brash AR, Jackson EK, Saggese CA, Lawson JA, Oates JA, FitzGerald GA.
    J Pharmacol Exp Ther; 1983 Jul 10; 226(1):78-87. PubMed ID: 6345756
    [Abstract] [Full Text] [Related]

  • 19. Metabolism of prostacyclin and 6-keto-prostaglandin F1 alpha in man.
    Rosenkranz B, Fischer C, Reimann I, Weimer KE, Beck G, Frölich JC.
    Artery; 1980 Jul 10; 8(1):18-22. PubMed ID: 7000039
    [Abstract] [Full Text] [Related]

  • 20. The role of the kidney in the metabolism of prostacyclin by the 15-hydroxyprostaglandin dehydrogenase pathway in vivo.
    Förstermann U, Neufang B.
    Biochim Biophys Acta; 1984 May 11; 793(3):338-45. PubMed ID: 6370311
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.